Last reviewed · How we verify
POTASSIUM LACTATE
At a glance
| Generic name | POTASSIUM LACTATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1986 |
Approved indications
Common side effects
Key clinical trials
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (PHASE2)
- Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance (NA)
- Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
- Clinical Effects of Ringers Lactate Versus Sterofundin/ Plasmalyte Solution in Patients With Sepsis (NA)
- UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients (PHASE1)
- Predicting 28-Day Survival in OHCA Patients
- MAGIK for Femoral/Tibial Shaft Fractures (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- POTASSIUM LACTATE CI brief — competitive landscape report
- POTASSIUM LACTATE updates RSS · CI watch RSS